Arie Belldegrun - 14 Mar 2022 Form 4/A - Amendment Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact for Arie Belldegrun
Issuer symbol
ALLO
Transactions as of
14 Mar 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
01 Apr 2022, 17:40:26 UTC
Date Of Original Report
31 Mar 2022
Previous filing
14 Jan 2022
Next filing
25 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Other $0 -4,710,120 -100% $0.000000* 0 14 Mar 2022 See footnote F2
transaction ALLO Common Stock Other $0 +4,710,120 $0.000000 4,710,120 14 Mar 2022 See footnote F1, F2
holding ALLO Common Stock 371,910 14 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the share holdings reported on the Form 4 filed by the reporting person on March 31, 2022.
F2 These shares were sold by Bellco Legacy IV LLC, of which the reporting person and Rebecka Belldegrun are managers, to Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary. In exchange for the shares, the reporting person received a promissory note in the principal amount of $36,032,418.00.